Literature DB >> 319104

Enzyme-labelled immunoassay for plasma cortisol.

T Ogihara, K Miyal, K Nishi, K Ishibashi, Y Kumahara.   

Abstract

An enzyme-labelled immunoassay for plasma cortisol was developed. For this alkaline-phosphatase was conjugated through 21-hemisuccinate of cortisol using water-soluble carbodiimide. An antibody was raised in rabbits against corisol-21-hemisuccinate bovine serum albumin. Before assay 10 mul samples of plasma were mixed with glutamate buffer, pH 3.3, and boiled to denature endogenous cortisol-binding globulin and alkaline-phosphatase. Separation of "bound and free" cortisol was done by the double antibody method. A linear relationship was obtained between the volume of plasma and the amount of cortisol. The minimal detectable level of plasma cortisol was 1 mug/dl and the coefficients of variation were 2.7%-4.4% (within assays) and 4.7%-6.0% (between assays). Cortisol values determined by the present method correlated well with those determined by radioimmunoassay. The present method of enzyme-labelled immunoassay is suitable for routine clinical analysis of plasma cortisol.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 319104     DOI: 10.1210/jcem-44-1-91

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Enzymes as versatile labels and signal amplifiers for monitoring immunochemical reactions.

Authors:  T T Ngo; H M Lenhoff
Journal:  Mol Cell Biochem       Date:  1982-04-16       Impact factor: 3.396

Review 2.  Enzyme immunoassays with special reference to ELISA techniques.

Authors:  A Voller; A Bartlett; D E Bidwell
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

3.  Amplification immunoassay for the determination of hepatitis B surface antigen.

Authors:  A Seki; E Tamiya; I Karube
Journal:  Appl Biochem Biotechnol       Date:  1991-03       Impact factor: 2.926

4.  Quantification of digoxin by enzyme immunoassay: synthesis of a maleimide derivative of digoxigenin succinate for enzyme coupling.

Authors:  N Monji; H Ali; A Castro
Journal:  Experientia       Date:  1980-10-15

5.  Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549).

Authors:  Cody P Coyne; Lakshmi Narayanan
Journal:  Drug Des Devel Ther       Date:  2016-08-12       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.